You might remember me from such articles as "Even Systematic Reviews are Pretty Easy to Manipulate" and "I Can Predict the Conclusion of Your Review Even Without Reading It". If you have been around for a while you may even remember me from "Industry-based Researchers get More Love Because They are Better Connected". In a web browser near you, see the … Continue reading Five tips for controlling the evidence base of your clinical intervention
So you’ve found a competing interest disclosure. Now what?
Published research varies across a spectrum that at one end is simply marketing masquerading as genuine inquiry. Actors in lab coats. To counter this problem, every time research is published in a journal, the authors are expected to declare anything that might have affected their impartiality in that work. Unfortunately, we very rarely do anything … Continue reading So you’ve found a competing interest disclosure. Now what?
Twitter users with anti-vaccine opinions are relatively easy to spot if we can measure their misinformation exposure
So...I have been systematically collecting tweets about human papillomavirus (HPV) vaccines since October 2013. We now have over two hundred thousand tweets that included keywords related to HPV vaccines, and the first of two pieces of research we have undertaken using these data has just been published in the Journal of Medical Internet Research. It covers 6 … Continue reading Twitter users with anti-vaccine opinions are relatively easy to spot if we can measure their misinformation exposure
How to predict the conclusion of a review without even reading it…
Short version: We published a new article in the Journal of Clinical Epidemiology all about selective citation in reviews of neuraminidase inhbitors - like Tamiflu and Relenza. Lots of reviews get written about drugs (especially the ones that get prescribed often), and the drugs used to treat and prevent influenza are no exception. There are more reviews written … Continue reading How to predict the conclusion of a review without even reading it…
Media collection about conflicts of interest in systematic reviews of neuraminidase inhibitors
As usual, I'm keeping a record of major stories in the media related to a recently published paper. I will continue to update this post to reflect the media response to our article in the Annals of Internal Medicine. Michael McCarthy from the BMJ covered the research, including asking extra questions. Melissa Davey from Guardian covered … Continue reading Media collection about conflicts of interest in systematic reviews of neuraminidase inhibitors
Should we ignore industry-funded research in clinical medicine?
A quick update to explain our most recent editorial [pdf] on evidence-based medicine published in the Journal of Comparative Effectiveness Research. It's free for anyone to access. What do we know? Industry funded research does not always lead to biases that are detrimental to the quality of clinical evidence, and biased research may come about for many … Continue reading Should we ignore industry-funded research in clinical medicine?
